GlassScriptPhysician profile
William J Namen
NPI 1063500692
$3,176.19
in general payments reported to CMS, 2019-2025
42 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $361 · 2021: $440 · 2022: $517 · 2023: $633 · 2024: $249 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997 · Debt Forgiveness: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.22 |
| Debt Forgiveness | $102.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $379.38 | 2020-2021 | |
| Sanara Medtech INC. | $361.00 | 2020-2023 | Celleraterx |
| Smith+Nephew, INC. | $317.46 | 2019-2025 | Collagenase Santyl, Oasis, Grafix Pl |
| Zyla Life Sciences, INC. | $268.22 | 2019 | |
| Averitas Pharma INC. | $233.49 | 2023-2025 | Qutenza |
| Horizon Therapeutics Plc | $162.54 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $145.20 | 2022-2025 | Nuzyra |
| Integra Lifesciences Corporation | $134.53 | 2019-2022 | |
| Djo, LLC | $102.83 | 2024 | |
| Bioventus LLC | $92.92 | 2019-2024 | Exogen Ultrasound Bone Healing System, Nexus-10 Mkii |
| Sebela Pharmaceuticals INC. | $86.07 | 2019-2020 | |
| Access Pro Medical, LLC | $83.64 | 2023 | Matriderm |
| Bone Support INC. | $78.69 | 2022 | |
| Melinta Therapeutics, LLC | $65.71 | 2019 | |
| Nabriva Therapeutics, Plc | $50.03 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $49.31 | 2025 | Krystexxa |
| Acera Surgical, INC. | $47.32 | 2022-2024 | Restrata Wound Matrix |
| Aroa Biosurgery Incorporated | $44.32 | 2023 | |
| Orthofix Medical, INC. | $40.45 | 2019-2025 | Physio-Stim |
| Medtronic, INC. | $38.23 | 2023-2025 | Inceptiv, Venaseal |
| Grt US Holding, INC. | $33.38 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $33.30 | 2023 | Seglentis |
| Assertio Therapeutics, INC. | $32.88 | 2019 | |
| Zimvie INC. | $27.61 | 2022 | |
| Merck Sharp & Dohme LLC | $26.25 | 2019 | |
| Kci USA, INC. | $26.01 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Wright Medical Technology, INC. | $25.49 | 2019 | |
| Corcept Therapeutics | $23.74 | 2023 | Korlym |
| Advanced Oxygen Therapy INC. | $23.03 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Depuy Synthes Sales INC. | $21.08 | 2023 | N/A, Na |
| Ibsa Pharma INC. | $18.87 | 2022 | |
| Abbvie INC. | $18.86 | 2021 | |
| Acell, INC. | $16.60 | 2019 | |
| Osiris Therapeutics INC. | $15.78 | 2019 | |
| Abbott Laboratories | $15.37 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $15.03 | 2022 | |
| Tenex Health INC. | $12.86 | 2020 | |
| Reprise Biomedical, INC. | $8.71 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Namen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.